This inventor holds 54 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Liposomal Drug Delivery. Top assignees: Tlc Biopharmaceuticals, Inc., Taiwan Liposome Company, Ltd., University of California. Active years: 2000-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Franciso, CA (US) (2001)
- South San Fracisco, CA (US) (2018)
- South San Francisco, AZ (US) (2020)
- San Francisco, CA (US) (2000 - 2023)
- South San Francisco, CA (US) (2014 - 2024)
Company Filing History:
23 out of 32 
22 out of 29 
12 out of 16,025 
Years Active: 2000-2026
Areas of Expertise:
Title: Keelung Hong: Innovating Drug Delivery Solutions
Introduction
Keelung Hong, a prolific inventor based in San Francisco, CA, has made significant contributions to the field of pharmacology with an impressive portfolio of 44 patents. Known for his groundbreaking work in sustained-release drug delivery systems, Hong's latest patents exemplify his innovative approach to enhancing the efficacy and convenience of anesthetic and therapeutic treatments.
Latest Patents
Hong's recent patents showcase his expertise in developing sustained-release compositions for enhanced drug delivery. One notable invention is the "Sustained-release anesthetic compositions and methods of preparation thereof," which introduces a novel anesthetic composition utilizing multilamellar vesicles to administer amide-type anesthetics effectively. This composition offers a prolonged duration of efficacy, making it ideal for localized drug delivery. Another patent, the "Pharmaceutical composition for intraarticular delivery," addresses the treatment of arthritis by providing a method for administering liposome-based sustained-release compositions containing therapeutic agents.
Career Highlights
Throughout his career, Hong has made significant contributions to companies such as Taiwan Liposome Company, Ltd., and Tlc Biopharmaceuticals, Inc. His expertise in drug delivery systems has not only earned him numerous patents but has also established him as a respected figure in the pharmaceutical industry. Hong's dedication to advancing medical treatments through innovative solutions underscores his commitment to improving patient care.
Collaborations
Hong's collaborations with esteemed colleagues such as Dmitri B Kirpotin and Yun-Long Tseng have further enriched his research endeavors. Their collective efforts have led to the development of cutting-edge drug delivery technologies that hold great promise for the future of pharmacology. By working closely with like-minded innovators, Hong has been able to exchange ideas, push boundaries, and create solutions that address unmet medical needs.
Conclusion
In conclusion, Keelung Hong's inventive spirit and dedication to revolutionizing drug delivery systems have positioned him as a trailblazer in the field of pharmacology. His latest patents not only demonstrate his ingenuity but also signify his unwavering commitment to advancing medical science. Hong's collaborative efforts and career achievements underscore his significant impact on the industry, paving the way for groundbreaking innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile